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Abstract Two new somatostatin analogs with a charac-
teristic part of the sequence -c(Cys-Phe-Trp-Lys-Thr-Cys)-
and with two histidine and two aspartic acid moieties in
their structures were synthesized and analyzed in terms of
their coordination abilities with copper (II) ions. Both
peptides bind Cu(II) effectively. Ligands form 4N com-




binding mode in a basic range
of pH. But in spite of very similar sequences of the two
peptides a significant difference in the effectiveness of the
binding of copper (II) ions was observed.
Keywords Somatostatin  Somatostatin analogs  Copper
complexes  Potentiometric measurements  Spectroscopy
Introduction
Many previous studies show that since the discovery of
somatostatin and its analogues interest in these peptides is
still unabated. They are used in a new way of cancer
treatment: peptide receptor radionuclide therapy (PRRT)
which is a very promising method used to treat patients
with neuroendocrine tumors. In PRRT, somatostatin analog
is connected with radionuclides by using a chelator like
DOTA or TETA and a linker (Teunissen et al. 2005).
The subjects of the presented study are two somatostatin
analogs with the part of the sequence: -c(Cys-Phe-Trp-Lys-
Thr-Cys)- which is characteristic for the peptide hormone.
Moreover, analyzed peptides have two histidine and two
aspartic acid moieties in the peptide chains (Fig. 1). Four
amino acids occurring between two cysteinyl moieties are
responsible for biological activities and interactions with
somatostatin receptors in this group of compounds (Paw-
likowski and Melen-Mucha 2004). Furthermore, the pres-
ence of His and Asp amino acid residues, which are
effective donors for metal ions, especially for copper (II)
(Sovago et al. 2006, 2012) allows to create a binding site
for a metal ion in the peptide structure. This way of the
metal ion binding would allow to eliminate a linker and a
chelator from precursors of radiopharmaceuticals poten-
tially useful in PRRT (Fig. 2).
Our previous studies of linear somatostatin analogs
show that analyzed ligands bind copper (II) ions effec-
tively. But, unfortunately, cyclic complexes that were
formed had structures not similar to natural hormone
peptides with disulfide bridge between two cysteinyl moi-
eties or the cyclic complex did not dominate in the phys-
iological range of pH (Marchewka et al. 2012; Marciniak
et al. 2012, 2014). Therefore, the analysis of cyclic ligands
is the next step in searching of new somatostatin analogs.
Materials and Methods
Synthesis of the Peptides
Peptides were synthesized by the standard manual Fmoc
solid-phase peptide synthesis method on the Fmoc-Rink
Amide MBHA resin (0.65 mM/g, Iris Biotech GmbH).
Synthesis was carried out in single-use plastic reactors
(Intavis GmBH). Functional groups in the side chains of
the amino acids used for the synthesis were protected as
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follows: Asp(OtBu), Cys(Acm), His(Trt), Lys(Boc),
Thr(tBu), Trp(Boc). Subsequent Fmoc-protected amino
acids (3 eq) were attached by using 3 eq PyBOP (1H-
benzotriazol-1-yloxy)(tri-1-pyrrolidinyl)phosphonium hex-
afluorophosphate as a coupling reagent in the presence of
N-hydroxybenzotriazole (3 eq) and diisopropylethylamine
(6 eq) for 2 h at room temperature. Fmoc protecting groups
were removed by 25 % piperidine in dimethylformamide.
Acetylation of the N-terminal amino group was performed
on the resin by 1:1 mixture of acetic anhydride and
0.4 M N-methylmorpholine in dimethylformamide. Final
cleavage of the peptides was achieved by ‘‘Reagent K’’
(81.5 % trifluoroacetic acid, 5 % phenol, 5 % thioanisole,
5 % water, 2.5 % ethanedithiol, 1 % triisopropylsilane) in
2 h at room temperature. Crude peptides, with Cys residues
still protected by Acm groups, were precipitated by cold
diethylether, washed with ether, dissolved in water and
lyophilized.
In order to remove Acm protecting groups from the side
chains of Cys residues and to form a disulfide bridge, pep-
tides were dissolved in 80 % acetic acid (2 mL of acetic acid
for 2 mg of a peptide) and 20 eq of I2 dissolved in a small
volume of 80 % acetic acid was added. The reaction was
performed under nitrogen and its progress was monitored by
ESI mass spectrometry until no more unoxidized peptide was
observed. Mixture was diluted with the same amount of
water and excess of I2 was extracted using CCl4. Water
fraction containing peptide was lyophilized.
Peptides were purified by semipreparative HPLC using
Varian ProStar apparatus equipped with TOSOH Bio-
science C18 column (300 A˚, 21.5 mm, 10 lm beads) and
220 nm UV detector. Water–acetonitrile gradients con-
taining 0.1 % TFA at a flow rate of 7 ml/min. were used
for the purifications. Final purity of the lyophilized pep-
tides was[95 % by analytical HPLC (Thermo Separation
Product; column: Vydac Protein RP C18, 250 A˚, 4.6 mm,
5 lm; linear gradient 0–100 % B in 60 min., solvent A—
0.1 % TFA in water, solvent B—0.1 % TFA in 80 %
acetonitrile:water solution, UV detection at 220 nm).
Chemical identity of the ligands was confirmed by ESI–MS
on a Bruker micrOTOF-Q or Bruker apex ultra mass
spectrometer. Analytical data of the synthesized peptides
are given in Table 1.
Potentiometric Measurements
Potentiometric measurements were carried out using Mol-
spin pH-meter system with Mettler Toledo InLab 422
semimicro combined electrode at 25 C calibrated in
hydrogen ion concentration using HCl (Irving et al. 1967).
The ligands concentration was 8 9 10-4 mol/L and pH-
metric titrations were performed in 0.1 mol/L KCl solution
using sample volumes of 1.2 mL. Alkali (NaOH) was
added by using a 0.25 ml micrometer syringe. The con-
centration of NaOH was 0.1 mol/L. Stability constants and
stoichiometry of the complexes were calculated from
titration curves using the SUPERQUAD program (Gans
et al. 1985). The pH range where precipitation was
observed was omitted during the calculations. Due to this
fact some stability constants were only estimated, which is
indicated in the ‘‘Results’’ section.
Fig. 1 Sequences of analyzed peptides
Fig. 2 The difference in ways of complexes forming between somatostatin analogs used in medicine (left) and somatostatin analogs described in
this study (right)
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Spectroscopic Measurements
Visible spectra of complexes were recorded at 25 C on
Varian Carry 50 Bio spectrophotometer. The electron
paramagnetic resonance (EPR) spectra were recorded on
Bruker ELEXSYS E500 CW-EPR, X-Band spectrometer,
equipped with ER 036TM NMR Teslameter and E 41 FC
frequency counter. The EPR simulated spectra and all EPR
parameters were obtained by the Biomolecular EPR
Spectroscopy Software of Wilfred R. Hagen (Hagen 2009).
Circular dichroism (CD) spectra were recorded on Jasco
J-1500 magnetic circular dichroism spectrometer in
230–800 nm range. The same concentrations were used for
both spectroscopic and potentiometric studies.
Fluorescence Measurements
Cary Eclipse fluorescence spectrophotometer was used for
fluorescence measurements with excitations at 280 nm for
both peptides. The concentrations for peptides solutions
were: 6.6 9 10-5 mol/L for Ac[D1,9H2,10]c(SST) and
6.7 9 10-5 mol/L for Ac[H1,9D2,10]c(SST). Measurements
were made at 25 C. The titration was performed at pH 8.0
and 11.0 as a function of metal concentration. The mea-
surements were done for pure ligands and for solutions
with ligand to metal ratios in the range of 1:0.1–1:4.0.
Results and Discussion
Both studied peptides have five protonation constants
assigned to two Asp, two His and one Lys amino acid
residues (Tables 2, 4) and they are comparable to those
found in the literature (Holm et al. 1996).
Analyzed somatostatin analog Ac[D1,9H2,10]c(SST)
starts copper (II) ion binding around pH 4 and creates
seven complexes (Fig. 3a). In the first one, CuH2L metal
ion is probably coordinated by one nitrogen atom deriving
from His residue. EPR parameters [A|| = 147 (cm
-1) and
g|| = 2.34, Table 3] confirm the existence of 1N complex.
Moreover, the logb* = 4.25 (where logb* = logbCuH2L -
logbH2L) supports additional involvement of the carboxy-
late group from the Asp side chain. This value is different
than logb* for complexes where metal ion is coordinated
only by imidazole nitrogen (Kapinos et al. 1998; Marciniak
et al. 2014). Next form, CuHL, dominates in the system
between pH 5.5 and 6 (Fig. 3a). The value of logb*CuHL–
HL = 6.03 may be connected with the involvement of the
second imidazole donor in copper (II) binding (Brasun´
et al. 2007). In this conditions CuL complex also exists in
the system. The value of logb = 8.78 (Table 2) may sup-
port involvement of the first amide nitrogen donor from the
peptide chain (Fig. 3a). Unfortunately, above pH 5 pre-
cipitation was observed in the solution and it continued to
pH 7.5. Molecules have a neutral charge there and this
could be the reason of the precipitation (Hashempour et al.
2010). Therefore, determination of spectroscopic parame-
ters for these two forms was not possible.
Next complex, CuH-1L, dominates in pH 7.5 (Fig. 3a).
The stoichiometry of this form suggests the loss of 6 pro-
tons from the ligand molecule. In these conditions lysyl
residue is still protonated, so it can be concluded that
besides two Asp and two His residues, two amide nitrogen
atoms are deprotonated. However, owing to the location of
both imidazole donors in the peptide chain, together with
deprotonation of two amide donors, the discussed complex





and thereby metal ion is coordinated here only by three
nitrogen atoms. The second His residue did not bind
metal ion. Spectroscopic results confirm the existence of
3N complex (Table 2). The experimental value of
kmax = 582 nm is in a good agreement with the theoretical
kmax = 584 nm calculated for two amides, one imidazole
nitrogen and one oxygen from water molecule donor sets
(Prenesti et al. 1999). Furthermore, the appearance of two
positive bands on CD spectrum at 247 and 323 nm
Table 1 Analytical data of the peptides
Peptide [M ? H]? [M ? 2H]2? [M ? 3H]3? Rt
c Preparative gradientd
Calc.a Foundb Calc.a Foundb Calc.a Foundb (min)
Ac[D1,9H2,10]c(SST) 1330.5092 n.o. 665.7582 665.7834 444.1746 444.1881 21.9 20–30 % B in 45 min
Ac[H1,9D2,10]c(SST) 1330.5092 n.o. 665.7582 665.7838 444.1746 444.1882 21.8 25–32 % B in 45 min
n.o. not observed
a Monoisotopic mas calculated for the indicated ion formed by the peptide
b Monoisotopic mas found by ESI–MS
c Retention time of the crude peptide found by analytical HPLC
d HPLC gradient used for the semipreparative purification of the peptide
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confirms the binding of copper (II) ion by both: imidazole
and amide nitrogen atoms, respectively (Table 2). Value of
logK = 7.18 obtained from potentiometric results also
suggest the involvement of the amide nitrogen atom in the
metal ion coordination (Table 2) (Kallay et al. 2009;
Marciniak et al. 2014).
Around pH 7 CuH-2L complex appears in the system.
The logK value of proton dissociation and formation of this
complex is equal to 8.21 and supports binding of the next
amide nitrogen and formation of the square planar complex




binding mode (Orfei et al. 2003).
The EPR parameters obtained for the system at pH 9
[A|| = 199 (cm
-1) and g|| = 2.194, Table 3] confirm
coordination of four nitrogen atoms to the metal ion (Pei-
sach and Blumberg 1974). Moreover, the components of g
tensor (gz  gy = gx[ 2.0023) show the axial symmetry
and the characteristic ACuII  ACu? splitting pattern sug-
gests the dx2-y2 ground state (Godlewska et al. 2013; Pap
et al. 2011). The comparison of the theoretical
Table 2 Potentiometric, UV–
Vis, and CD data for the Cu(II)/
Ac[D1,9H2,10]c(SST) system at
25 C, I = 0.1 mol/L (KCl)
Ac[D1,9H2,10]c(SST) log b log K UV–Vis CD
k (nm) e (M-1 cm-1) k (nm) De (M-1 cm-1]
HL 9.70 ± 0.02
H2L 16.61 ± 0.03
H3L 22.74 ± 0.03
H4L 26.74 ± 0.04






CuH2L 20.86 ± 0.06 – – – –
CuHL *15.73 ± 0.03 – – – –
CuL *8.78 ± 0.09 – – – –





CuH-2L -7.05 ± 0.06 523 68 626
a 0.88
579 sh 491a -1.11
321c 0.97
257b 6.29
CuH-3L -17.24 ± 0.06 523 74 626
a 0.88
579 sh 491a -1.11
321c 0.97
257b 6.29







The ligand concentration was 8 9 10-4 mol/L; 1:1 ligand to metal ratio
sh shoulder
a d–d transition
b NIm ? Cu(II) CT
c N- ? Cu(II) CT
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kmax = 523 nm (Prenesti et al. 1999) together with the
experimental kmax = 525 nm (Table 2) in absorption





this complex. Moreover, positive CT transition at 322 nm
(Table 2) shows major involvement of amide nitrogen
atoms in the metal ion binding.
Above pH 9 next two protons dissociate from the
molecule and CuH-3L and CuH-4L complexes are formed
(Fig. 3a). However, no changes in spectroscopic parame-
ters are observed. The logK value of formation of CuH-3L
complex (10.19, Table 2) suggests proton dissociation
from Lys residues. The creation of the CuH-4L may be a
result of the loss of a proton from the second nitrogen atom
in the imidazole ring from the histidine moiety involved in
copper ion coordination, what was observed in the case of
other His-peptides (Brasun´ et al. 2007).
The second somatostatin analog, Ac[H1,9D2,10]c(SST),
has different position of His and Asp moieties in the pep-
tide chain in comparison with the previously described
peptide. It creates seven types of complexes with copper(II)
ions (Fig. 3b). CuH3L coexists in the system with the next
one CuH2L and with the uncoordinated metal ion so it was
not possible to describe it using spectroscopic methods.
However, analysis of the potentiometric results may give
some suggestion. The value of logb* = 3.01, where
logb* = logbCuHnL - logbHnL, suggests the {NIm} binding
mode (Kapinos et al. 1998; Marciniak et al. 2014). More-
over, the logK = 4.45, for the reaction: CuH3L ? CuH2L
is comparable to the protonation constants for deprotona-
tion of one carboxylate group from Asp residues
(logK = 4.53) without binding to the metal ion (Table 4).
LogK = 5.24 for the reaction of CuHL formation sug-
gests proton dissociation from histidine moiety (Table 4).
Stoichiometry of the described form indicates the loss
of protons from two His residues. Therefore, {2NIm}
coordination mode is possible here. The value of
logb* = logKCuHL–logbHL = 6.55, which is similar to
logb* for the other complexes with the same coordination
mode in systems described in the literature (Brasun´ et al.
2007; Kotynia et al. 2014) confirms this type of copper (II)
binding.
Similarly to Ac[D1,9H2,10]c(SST), when CuL complex
with neutral charge exists in the system, precipitation was
observed. Therefore, determination of spectroscopic
parameters for CuL was not possible. Only on the basis of
the stoichiometry of the described complex it can be con-
cluded that the first amide nitrogen is involved in the metal
ion coordination.
(a) (b)
Fig. 3 Species distributions curves for a Cu(II)-Ac[D1,9H2,10]c(SST) and b Cu(II)-Ac[H1,9D2,10]c(SST) at 25 C; I = 0.1 mol/L KCl; ligand
concentration 8 9 10-4 mol/L; ligands to metal ratio 1:1; area of precipitation is shown in gray
Table 3 The EPR parameters obtained by simulation of spectra in Cu(II)/Ac[D1,9H2,10]c(SST) system
Species parameters CuH2L {NIm} CuH-1L {NIm, 2N
-} CuH-2L {NIm, 3N
-} CuH-3L {NIm, 3N
-}
gz (g||) 2.340 2.225 2.194 2.193
gx, gy (g\) 2.079 2.057 2.042 2.042
Az
Cu (A||)





8 22 23 23
a [A] = 10-4 cm-1
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While pH increases, next three complexes: CuH-1L,
CuH-2L; and CuH-3L appear in the system (Fig. 3b).
Coordination modes for these forms are the same as in case
of Ac[D1,9H2,10]c(SST) analog, what is confirmed by
potentiometric and spectroscopic parameters (Tables 4, 5).
It is difficult to define which histidine moieties are
involved in the coordination of copper (II) ion in the par-
ticular complexes. In case of 4 N complexes with {NIm,
3N-} coordination modes two options for each of the
peptides are possible (Fig. 4). However, in view of the
creation of (6,5,5)-chelate rings in case of copper (II) ion
coordination by histidine moieties on C-terminal of pep-
tides chains, this way of binding seems to be energetically
more favorable than the second one where (7,5,5)-chelate
rings are created (Sovago et al. 2012). Therefore, coordi-
nation by His10 in Ac[D1,9H2,10]c(SST) and His9 in
Ac[H1,9D2,10]c(SST) is much more probable.
Table 4 Potentiometric and
spectroscopic data for the
Cu(II)/Ac[H1,9D2,10]c(SST)
system at 25 C, I = 0.1 mol/L
(KCl)
Ac[H1,9D2,10]c(SST) log b log K UV–Vis CD
k (nm) e (M-1 cm-1) k (nm) De (M-1 cm-1)
HL 10.10 ± 0.01
H2L 17.15 ± 0.02
H3L 23.33 ± 0.01
H4L 27.46 ± 0.02






CuH3L 26.34 ± 0.06 – – – –
CuH2L 21.89 ± 0.04 – – – –
CuHL *16.65 ± 0.06 – – – –
CuL *10.85 ± 0.08 – – – –




CuH-2L -5.39 ± 0.02 556 99 557
a -0.435
282b,c 1.69










The ligand concentration was 8 9 10-4 mol/L; 1:1 ligand to metal ratio
sh shoulder
a d–d transition
b NIm ? Cu(II) CT
c N- ? Cu(II) CT
Table 5 The EPR parameters obtained by simulation of spectra in
Cu(II)/Ac[H1,9D2,10]c(SST) system
Species parameters CuH-1L {NIm, 2N
-} CuH-2L {NIm, 3N
-}
gz (g||) 2.224 2.201









a [A] = 10-4 cm-1
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Tryptophan is responsible for the phenomenon of fluo-
rescence in both analyzed peptides (Lakowicz 2006). In the
manner of the metal ion binding for CuH-2L complexes
proposed above no atoms derived from this amino acid
residue are involved in the coordination of Cu(II). There-
fore, study of the fluorescence quenching in analyzed
systems could be an indication that described binding
manners are possible. Analysis in pH 8.0 and 11.0 show
that in both peptides quenching of fluorescence is very
similar (Fig. 5). In the analyzed conditions in both systems
the same types of complexes with the same coordination
modes are formed. In all cases almost 100 % of fluores-
cence is quenched. It means that tryptophan residues are
located on the surface of the complexes and are not pro-
tected from the quencher by the rest of the molecule. It can
be concluded that fragments of the peptide chains with
tryptophan residues have similar spatial arrangement in
both ligands. Therefore, the proposed coordination modes
with involvement of histidine moieties on C-terminal are
possible.
Fluorescence quenching was also analyzed by Stern–
Volmer equation (Lakowicz 2006) (Fig. 6). Obtained plots
indicate mixed mechanism of quenching: static and
dynamic.
Figure 7 shows the comparison of the efficiency in
copper (II) ion binding between the two analyzed peptides.
Both ligands have a very similar construction but
Ac[H1,9D2,10]c(SST) coordinates copper (II) ion much
better than the second one in the whole analyzed range of
pH. It is probably related to the earlier (in lower pH)
coordination of amide nitrogen atoms in case of Ac[H1,9-
D2,10]c(SST)/Cu2? system (first amide nitrogen coordi-
nates to copper (II) ions in CuL complexes in both
(a)
(b)
Fig. 4 Two possible manners of Cu(II) coordination in CuH-2L complexes for: a Ac[D
1,9H2,10]c(SST), b Ac[H1,9D2,10]c(SST)
Fig. 5 Fluorescence quenching for Ac[D1,9H2,10]c(SST) and Ac[H1,9
D2,10]c(SST) as a function of increasing Cu2? concentration in pH 8.0
and 11.0
Fig. 6 Stern–Volmer plots for copper (II) quenching of fluorescence
for Ac[D1,9H2,10]c(SST) and Ac[H1,9D2,10]c(SST)
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systems). Moreover, the ligand with histidine moiety in the
first position coordinates the metal ion by amide nitrogen
from Cys8 in CuH-1L complex. This is the first amino acid
which is involved in the coordination and it occurres within
the cyclic structure. In case of Ac[D1,9H2,10]c(SST) similar
situation is observed later in the CuH-2L complex. It can
also affect the difference in the effectiveness in copper (II)
ion coordination.
Presented results demonstrated that small modifications
within the peptide sequence can significantly affect effi-
ciency of the metal ion binding.
Conclusion
In this paper we have shown that new somatostatin analogs
with the characteristic part of the sequence -c(Cys-Phe-
Trp-Lys-Thr-Cys)- and with two histidine and two aspartic
acid moieties in their structures bind copper(II) ions
effectively. Both ligands have very similar construction but
Ac[H1,9D2,10]c(SST) coordinates copper (II) ion much
better than the second one in the whole analyzed range of
pH. It was shown that small modifications within the
peptide sequence can significantly affect efficiency of the
metal ion binding. These results may be an introduction to
the discovery of new precursors of pharmaceuticals useful
in the PRRT.
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